Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Whiting

Showing results (121-130 of 244) with videos related to

Pageof 25
Sort By:
Biochemical Pharmacology|December 3, 1993
Alleviation of experimental cyclosporin A nephrotoxicity by low dose aspirin in the ratK E Adams, P A Brown, S D Heys, et al.
British Journal of Experimental Pathology|August 1, 1983
Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeksP H Whiting, J G Simpson, R J Davidson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 20, 1980
Patterns of N-acetyl-beta-D-glucosaminidase excretion after renal transplantationP H Whiting, A J Nicholls, G R Catto, et al.
Clinical and Experimental Immunology|February 1, 1995
Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancerW G Simpson, S D Heys, P H Whiting, et al.
Transplantation|January 1, 1989
Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporineM Stephen, J Woo, N U Hasan, et al.
Connective Tissue Research|January 1, 1982
Immunological studies with human aortic elastinK Barnard, S M Partridge, A H Whiting, et al.
Biochemical Society Transactions|August 1, 1997
Ischaemia-reperfusion injury during peripheral arterial surgery--the effect of nitric oxideP H Whiting, R Naylor, G G Cooper, et al.
Biochemical Society Transactions|November 1, 1994
Pre-operative recombinant interleukin-2 and increased nephrotoxicityD J Deehan, S D Heys, J Broom, et al.
Joint Commission Journal on Quality and Patient Safety|November 8, 2012
Reducing ventriculostomy-related infections to near zero: the eliminating ventriculostomy infection studyMaryam Rahman, Jobyna H Whiting, Loretta L Fauerbach, et al.
Renal Failure|January 1, 1993
Lithium clearance measurements during recombinant interleukin 2 treatment: tubular dysfunction in manS D Heys, O Eremin, C R Franks, et al.
Pageof 25

Showing results (121-130 of 244) with videos related to

Sort By:
Pageof 25
Biochemical Pharmacology|December 3, 1993
Alleviation of experimental cyclosporin A nephrotoxicity by low dose aspirin in the ratK E Adams, P A Brown, S D Heys, et al.
British Journal of Experimental Pathology|August 1, 1983
Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeksP H Whiting, J G Simpson, R J Davidson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 20, 1980
Patterns of N-acetyl-beta-D-glucosaminidase excretion after renal transplantationP H Whiting, A J Nicholls, G R Catto, et al.
Clinical and Experimental Immunology|February 1, 1995
Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancerW G Simpson, S D Heys, P H Whiting, et al.
Transplantation|January 1, 1989
Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporineM Stephen, J Woo, N U Hasan, et al.
Connective Tissue Research|January 1, 1982
Immunological studies with human aortic elastinK Barnard, S M Partridge, A H Whiting, et al.
Biochemical Society Transactions|August 1, 1997
Ischaemia-reperfusion injury during peripheral arterial surgery--the effect of nitric oxideP H Whiting, R Naylor, G G Cooper, et al.
Biochemical Society Transactions|November 1, 1994
Pre-operative recombinant interleukin-2 and increased nephrotoxicityD J Deehan, S D Heys, J Broom, et al.
Joint Commission Journal on Quality and Patient Safety|November 8, 2012
Reducing ventriculostomy-related infections to near zero: the eliminating ventriculostomy infection studyMaryam Rahman, Jobyna H Whiting, Loretta L Fauerbach, et al.
Renal Failure|January 1, 1993
Lithium clearance measurements during recombinant interleukin 2 treatment: tubular dysfunction in manS D Heys, O Eremin, C R Franks, et al.
Pageof 25